Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease

Previously, we demonstrated that the proton pump inhibitor, esomeprazole magnesium hydrate (MH), could have potential as a repurposed treatment against preeclampsia, a serious obstetric condition. In this study we investigate the difference in the preclinical effectiveness between 100 µM of esomepra...

Descripción completa

Detalles Bibliográficos
Autores principales: de Alwis, Natasha, Fato, Bianca R., Beard, Sally, Binder, Natalie K., Kaitu’u-Lino, Tu’uhevaha J., Onda, Kenji, Hannan, Natalie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455231/
https://www.ncbi.nlm.nih.gov/pubmed/36076929
http://dx.doi.org/10.3390/ijms23179533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455231/
https://www.ncbi.nlm.nih.gov/pubmed/36076929
http://dx.doi.org/10.3390/ijms23179533

Ejemplares similares